skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Radioiodine total body scan versus serum thyroglobulin levels in follow-up of patients with thyroid cancer

Journal Article · · Surgery; (United States)
OSTI ID:5428208

Two groups of patients were studied to compare the efficacy of serum thyroglobulin (Tg) levels to /sup 131/I total body scans in the follow-up of patients with thyroid cancer. All of the group of 30 patients without recurrence had undetectable Tg levels on and off thyroid hormone replacement, and all had negative total body scan results although eight patients showed uptake in remnant thyroid tissue. In the second group of 37 patients with documented recurrent or metastatic disease, 34 (92%) had positive serum Tg levels, although the levels in five of these patients were undetectable while on thyroid replacement, and 31 (84%) had positive total body scan results. The false negative results of the two tests were not overlapping, and of those with positive Tg levels, 29 showed a significant increase once thyroid hormone therapy had been withdrawn. We conclude that although the percentages of positive Tg levels and body scan results in patients with recurrent disease are similar, both tests are required to minimize the number of patients with undiagnosed metastases. Second, thyroid-stimulating hormone suppression has a definite although unpredictable effect on serum Tg levels in patients with thyroid cancer, and thyroid hormone should be withdrawn prior to measurement of serum Tg to minimize the number of false negative results.

Research Organization:
Department of Surgery, College of Physicians and Surgeons of Columbia University, New York
OSTI ID:
5428208
Journal Information:
Surgery; (United States), Vol. 91:1
Country of Publication:
United States
Language:
English

Similar Records

Sequential serum thyroglobulin determinations, /sup 131/I scans, and /sup 131/I uptakes after triiodothyronine withdrawal in patients with thyroid cancer
Journal Article · Tue Dec 01 00:00:00 EST 1981 · J. Clin. Endocrinol. Metab.; (United States) · OSTI ID:5428208

Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer
Journal Article · Tue Mar 01 00:00:00 EST 1988 · Cancer (Philadelphia); (United States) · OSTI ID:5428208

Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels
Journal Article · Tue Dec 01 00:00:00 EST 1987 · J. Nucl. Med.; (United States) · OSTI ID:5428208